Use of VEGF as a pro-angiogenic treatment for cardiac and limb ischemia has generated intense interest but direct administration of VEGF has not yet produced effective results in humans, and initial trials of transplantation of angiogenic cells have proven effective but require further work [16–18]. Here, VEGFA is linked to limb ischemia.